Wacker Biotech B.V. Paalbergweg 2
FDA inspection history in Amsterdam, Netherlands, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at Amsterdam, Netherlands.
Cited most
Across all Wacker Biotech B.V. Paalbergweg 2 observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.160General requirements1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.67Equipment cleaning and maintenance1
- 21 CFR 211.68Automatic, mechanical, and electronic equipment1
The complete Wacker Biotech B.V. Paalbergweg 2 file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Amsterdam, Netherlands
One Form 483 · 2025 · 5 observations
Latest: Form 483, Nov 21, 2025 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-11-21 | 483 Form 483 | Amsterdam, Netherlands | 5 | $99 |
FEI number 3008539577 · most recent document Nov 21, 2025
About Wacker Biotech B.V. Paalbergweg 2
How many FDA Form 483s has Wacker Biotech B.V. Paalbergweg 2 received?
FDA Intel has 1 Form 483 on file for Wacker Biotech B.V. Paalbergweg 2; the most recent is dated Nov 21, 2025.
When was Wacker Biotech B.V. Paalbergweg 2 last inspected by FDA?
The most recent FDA inspection document on file for Wacker Biotech B.V. Paalbergweg 2 is a Form 483 dated Nov 21, 2025, for the site in Amsterdam, Netherlands.
What did FDA cite at Wacker Biotech B.V. Paalbergweg 2?
The regulations cited most in the observations on file for Wacker Biotech B.V. Paalbergweg 2 are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.165 (Testing and release for distribution), 1 time.